C Rad Ab Stock Fundamentals

CRAD-B Stock  SEK 29.95  0.85  2.92%   
C Rad AB fundamentals help investors to digest information that contributes to C Rad's financial success or failures. It also enables traders to predict the movement of CRAD-B Stock. The fundamental analysis module provides a way to measure C Rad's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to C Rad stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

C Rad AB Company Operating Margin Analysis

C Rad's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current C Rad Operating Margin

    
  0.07 %  
Most of C Rad's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, C Rad AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, C Rad AB has an Operating Margin of 0.0724%. This is 100.21% lower than that of the Healthcare sector and 100.11% lower than that of the Diagnostics & Research industry. The operating margin for all Sweden stocks is 101.31% lower than that of the firm.

C Rad AB Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining C Rad's current stock value. Our valuation model uses many indicators to compare C Rad value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across C Rad competition to find correlations between indicators driving C Rad's intrinsic value. More Info.
C Rad AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  1.33  of Return On Asset per Return On Equity. Comparative valuation analysis is a catch-all model that can be used if you cannot value C Rad by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for C Rad's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

CRAD-B Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses C Rad's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of C Rad could also be used in its relative valuation, which is a method of valuing C Rad by comparing valuation metrics of similar companies.
C Rad is currently under evaluation in operating margin category among its peers.

CRAD-B Fundamentals

About C Rad Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze C Rad AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of C Rad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of C Rad AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
C-Rad AB , together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. C-Rad AB was founded in 2004 and is headquartered in Uppsala, Sweden. C RAD operates under Diagnostics Research classification in Sweden and is traded on Stockholm Stock Exchange. It employs 54 people.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in CRAD-B Stock

C Rad financial ratios help investors to determine whether CRAD-B Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CRAD-B with respect to the benefits of owning C Rad security.